Status:
ACTIVE_NOT_RECRUITING
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Conditions:
Esophageal Cancer (EsC)
Eligibility:
All Genders
18-90 years
Brief Summary
This single-center, retrospective, 7-year observational study aims to investigate prognostic factors in esophageal cancer patients. Adults (≥18 years) with histologically confirmed esophageal cancer w...
Eligibility Criteria
Inclusion
- Waiver of informed consent for deceased or lost-to-follow-up patients (January 2017-March 2024)
- Voluntary signed informed consent from surviving patients who could be contacted
- Treatment at Nanfang Hospital, Southern Medical University (January 2017-December 2024)
- Received antitumor therapy for esophageal cancer
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2
Exclusion
- Concurrent other malignancies
- Patients deemed ineligible by investigators
Key Trial Info
Start Date :
April 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06960889
Start Date
April 15 2025
End Date
June 30 2026
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital, Southern Medical University
Guangzhou, Guangzhou, China, 510515